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INTRODUCTION
Tongue cancer is the most common intra-oral
malignancy in Western countries. It accounts for
between 20 to 50 per cent of all malignancies involving
the oral cavity.1 More males than females are affected
and the highest incidence occurs in the seventh decade
of life.1,2 The vast majority of tongue malignancies,
more than 95 per cent, are squamous cell carcinomas
(SCC).1,2 The lateral border and the base of the tongue
are the most commonly involved sub-sites of the
tongue. Indeed in some studies, the base of the tongue
accounts for up to one-third of all SCC of tongue.3 The
aetiological agents that are considered most important
with respect to SCC of the tongue include tobacco
(smoking and chewing habits) and alcohol
consumption.1,2
The incidence and mortality of the disease varies
between different geographic areas. There has been a
reported increased incidence of tongue SCC and
associated mortality over recent decades in Europe and
the United States.2,4,5 Additionally, an increased
incidence of SCC of the tongue in young adults has
been reported from studies conducted in several
countries.2-6 Approximately 5–10 per cent of cases of
tongue cancer occur in younger patients, many of
whom do not have the identified risk factors such as
smoking and alcohol.6 Debate continues in the
literature regarding the aetiology, tumour biology and
prognosis of tongue cancer in young patients.
In spite of advances in cancer therapy, the worldwide
trend in five-year survival rates of tongue SCC since the
early 1970s has remained relatively constant,
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Abstract
Background: Tongue cancer (141 ICD-9) is the most
common intra-oral malignancy in Western countries.
In recent decades, reported tongue cancer incidence
and mortality rates have increased both in Europe
and in the United States, whilst survival has not
improved. This study aimed to determine the
epidemiology and survival trends of tongue cancer in
South Australia over the 24-year period from 1977
to 2001.
Methods: Population-based data for tongue cancer
were provided by the Central Cancer Registry Unit
of the Epidemiology Branch of the South Australian
Department of Health. Age-standardized incidence
and mortality rates for males and females were
calculated. Kaplan-Meier survival analysis was
conducted according to time periods, age, sex and
tongue sub-sites. Cox regression analysis was used
to determine factors that influenced survival.
Results: During this 24-year period, 611 cases of
tongue cancer (398 males, 213 females) were
reported, the majority of which were squamous cell
carcinomas. The most common age of diagnosis was
65–69 years in males and 60–64 years in females.
Fifty cases (8.18 per cent of all tongue cancer cases)
occurred in patients 40 years or younger. The most
common cancer sub-sites reported were ‘unspecified
site’ (48.45 per cent), lateral border (25.53 per cent)
and base (18.49 per cent) of the tongue. The age-
standardized incidence and mortality rates for males
and females in South Australia were relatively low
and stable, and there was no significant
improvement in survival of tongue cancer over this
period. Significant predictors for survival were sex,
age and tongue sub-sites, with male, advanced age
and base of tongue associated with poorer survival.
Conclusions: Tongue cancer is an important health
issue associated with poor survival. Early detection
and diagnosis is important in order to improve
survival rate for this malignancy.
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approximately 50 per cent in developed countries.1,2
Many factors related to the patient, tumour and
treatment have been identified to predict the survival of
patients with tongue cancer.4,7 Among them, the
tumour, node, metastasis (TNM) stage at which the
disease is diagnosed is the single most important
predictor for survival.1 The presence of cervical node
metastases dramatically reduces the five-year survival
rate to 15–30 per cent, as compared to 50 per cent for
those without nodal involvement.1-3 Poorer survival is
also related to the male gender, advanced age, posterior
location of the tumour and delay in treatment.2,7
The aims of this study were twofold: (1) to analyse
the epidemiological pattern of tongue cancer in South
Australia over the 24-year period, 1977–2001, with
respect to the incidence, mortality and five-year
survival trends; and (2) to identify statistically
significant predictors for survival of tongue cancer
which are available on the population-based South
Australian Cancer Registry database.
MATERIALS AND METHODS
The data for the study were provided by the Central
Cancer Registry of the Epidemiology Branch of the
South Australian Department of Health. This
population-based cancer registry processes statutory
notifications from all hospitals, pathology laboratories,
radiotherapy departments, and the South Australian
Registrar of Deaths for all cases of invasive cancer
which have occurred in South Australia since 1977.
The Cancer Registry also has access to population
statistics from the Australian Bureau of Statistics thus
allowing calculation of population-based incidence and
mortality rates. Cancer cases are coded according to
The International Classification of Disease, ninth
edition (ICD-9). The sub-sites for tongue cancer (141
ICD-9) consist of the following: (1) Base of tongue
(141.0 ICD-9); (2) Dorsal surface (141.1 ICD-9); (3)
Tip and lateral border (141.2 ICD-9); (4) Ventral
surface/anterior two thirds (141.3 ICD-9); (5) Tongue
‘unspecified site’ (141.9 ICD-9). The pathological type
or morphology of cancer cases is coded according to
The International Classification of Diseases for
Oncology, second edition (ICD-O).9
Statistical analysis
The total number of cases and the number of cases
according to sex, age and sub-site distributions of
tongue cancer in South Australia between 1977–2001
were analysed using the Intercooled Stata 8.0 statistical
software.10 The level of statistical significance between
various parameters was assessed on PEPI Version 4.011
using 95 per cent confidence intervals (p<0.05).
Age-specific incidence and mortality rates for males
and females were calculated using the South Australia
Census Postcode Population for the years 1981, 1991
and 1996 provided by the Australian Bureau of
Statistics. Age-standardized incidence and mortality
rates were then calculated for males and females to
world population for time periods 1977–1985,
1986–1993 and 1994–2001 using Microsoft® Excel
Software. For analysis of survival trend of tongue
cancer, cases were divided according to periods of
diagnosis (1977–1985, 1986–1993 and 1994–2001),
sex, age groups (≤59, 60–69 and ≥70 years) and tongue
sub-sites (ICD-9). Survival curves were constructed
using the method of Kaplan-Meier.12 Cox proportional
hazards analysis was used to identify statistically
significant predictors for tongue cancer that were
available on the Cancer Registry database, namely time
period of diagnosis, sex, age groups and tongue sub-
sites. All factors related to survival that had achieved
significance levels of 0.05 or less on the univariate
regression analysis were incorporated into a
multivariable model.
RESULTS
Number of tongue cancer cases
The number of cases of tongue cancer reported in
South Australia during the 24-year period between
1977 and 2001 are presented in Table 1. Significantly
more males (65.14 per cent) than females (34.86 per
cent) were diagnosed with tongue cancer with a
male:female ratio of 1.9:1 (p<0.001). The tongue was
the most common intra-oral site for oral cancer,
comprising 44.9 per cent of intra-oral malignancies.
Tongue cancers represented 0.41 per cent of all cancers
recorded by the Cancer Registry over this period and
the majority of tongue cancers were squamous cell
carcinomas (97.21 per cent).
Age of diagnosis of tongue cancer
Figure 1 shows the number of tongue cancer cases
according to age at diagnosis. A significant association
was found between the number of tongue cancer cases
and increasing age for both sexes (p>0.01). Of the total
number of tongue cancer cases, there were 50 cases (31
males, 19 females) occurring in patients 40 years or
younger, which represented 8.18 per cent of total
tongue cancer cases.
Sub-sites of tongue involved
The total number of cases reported for each tongue
sub-site and the number of cases reported according to
sex are presented in Table 2. Tongue ‘unspecified site’
(141.9 ICD-9) was the most commonly reported cancer
sub-site accounting for 48.45 per cent of the total
number of tongue cancer cases in South Australia
between 1977–2001.
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Table 1. Oral cancer cases reported between
1977–2001 (excluding lip cancer and major salivary
gland malignancy)
Primary cancer site (ICD-9) Number of cases
Tongue (ICD-9 141) 611 (44.9%)
Gum (ICD-9 143) 84 (6.2%)
Floor of mouth (ICD-9 144) 296 (21.8%)
‘Other mouth’ (ICD-9 145) 369 (27.1%)
Total 1360 (100%)
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Males had significantly more reported tongue cancer
occurring at the base, tip and lateral border and at an
unspecified site of the tongue, with the male-to-female
ratio for base of tongue cancer being 3.35:1 (p<0.001).
The number of reported cases for each tongue sub-
site according to the three time periods of diagnosis is
presented in Table 3.
Incidence and mortality of tongue cancer
Age-standardized incidence and mortality rates for
tongue cancer in South Australia for the three
diagnostic periods of 1977–1985, 1986–1993 and
1994–2001 are presented in Table 4. Although the 
age-standardized incidence rate of tongue cancer 
for males demonstrated an increasing trend over the
years 1977–2001, there was no significant difference
between the three time periods. Similarly, age-
standardized mortality rates for males remained stable
over the 24-year period. In females, there was no
significant change in the parameters of age-
standardized incidence or mortality rates of tongue
cancer over time. Males demonstrated significantly
higher incidence and mortality rates than females
during all three periods.
Analysis of five-year survival trends for tongue cancer
The Kaplan-Meier survival curves by periods of
diagnosis, age group, sex and tongue sub-sites are
presented in Figs 2–5.
Survival by time period of diagnosis
Cox proportional hazards regression analysis
revealed no significant difference between periods of
diagnosis. However, it can be seen that survival for the
two most recent time periods, 1986–1993 and
1994–2001, fall below the survival curve for
1977–1985 (Fig 2). Although not statistically
significant, this finding suggests that survival has not
improved in recent years.
Survival by sex
Males demonstrated a significantly poorer (p=0.025)
five-year survival curve than females (Fig 3). The steep
decline in the curves during the first two years indicated
that mortality is greatest within this period of the
disease, after two years there was a continual decline of
the male curve.
Survival by age groups
Kaplan-Meier survival curves for the three age
groups of ≤59, 60–69 and ≥70 years old are presented
in Fig 4. The youngest age group accounted for 35.84
per cent (n=219) of cases, the middle age group 32.08
per cent (n=196), and the oldest age group 32.08 per
cent (n=196) of cases of tongue cancer. The oldest age
group demonstrated the worst survival, followed by the
60–69 years group, with those aged less than 59 years
having the best survival. These differences were
statistically significant (p=0.041).
Fig 1. Tongue cancer in South Australia, 1977-2001: age at
diagnosis.
Table 2. Tongue cancer in South Australia, 1977–2001: number of cases reported at each sub-site (ICD-9) and
male to female distribution and ratio
Primary cancer site (ICD-9) Number of cases Male Female Male:Female ratio p
Base of tongue (141.0) 113 (18.49%) 87 26 3.35:1 <0.001
Dorsal surface (141.1) 10 (1.64%) 5 5 1:16 5 N/S
Tip and lateral border (141.2) 156 (25.53%) 101 55 1.84:1 <0.001
Ventral surface/anterior 2/3 (141.3) 36 (5.89%) 16 20 0.8:16 0.189
Tongue ‘unspecified site’ (141.9) 296 (48.45%) 189 107 1.73:1 <0.001
Total 611 (100%) 6 398 213
Table 3. Tongue cancer in South Australia, 1977–2001: tongue sub-sites (ICD-9) to number of cases diagnosed in
the time periods of diagnosis
Tongue sub-sites (ICD-9) 1977-85 1986-93 1994-2001 Sub-site total
Base of tongue (141.0) 17 41 55 113
Dorsal surface (141.1) 1 3 6 10
Tip and lateral border (141.2) 32 53 71 156
Ventral surface/anterior 2/3 (141.3) 8 13 15 36
Tongue ‘unspecified site’ (141.9) 133 81 82 296
Total for each period 191 191 229 611
Survival by sub-sites of tongue
Cancer involving the base of tongue has significantly
worse survival than other tongue sub-sites (p=0.033).
The Kaplan-Meier survival curve showed a steep
decline over the first two years, followed by a slower
decline thereafter. Better survival was evident for
tongue ‘unspecified site’, tip and lateral border, dorsal
surface and ventral surface/anterior two-thirds (Fig 5).
Predictors for tongue cancer survival
Univariate analysis using Cox’s proportional hazard
regression showed sex, age and sub-site of tongue to be
statistically significant for predicting tongue cancer
survival (p=0.025, 0.041 and 0.033, respectively).
Specifically, male, increasing age and base of tongue
sub-site were found to negatively affect survival.
Multivariable analysis revealed that the base of tongue
sub-site was the most significant factor in predicting
tongue cancer survival, even after controlling for sex
and age (p=0.002).
DISCUSSION
This study investigated various epidemiological
parameters related to tongue cancer in South Australia
reported over the 24-year period 1977–2001. Cancer of
the tongue accounted for the majority of oral cancers
(excluding lip cancer and major salivary gland
malignancies) and was most common in males and in
the seventh decade of life. The vast majority of tongue
cancers were squamous cell carcinomas and this was in
accordance with findings of studies conducted in
Europe, the United States, as well as other states of
Australia.2,5,6,13 The most commonly reported sub-sites
were ‘unspecified site’, tip and lateral border and base
of the tongue. Interestingly, almost 45 per cent of the
cases reported to occur on an ‘unspecified site’ were
reported during the earliest time period, 1977–1985
(Table 3), which could reflect less specific
documentation of cancer site in earlier years.
Compared with other Australian states, the incidence
of tongue cancer in males in South Australia is low.2,13
For example, the incidence is 2.1 per 100 000 per
annum in Victoria and 2.8 per annum in Western
Australia.2 Roder and Wilson14 reported a male
incidence rate of 1.8 per 100 000 per annum in South
Australia between 1977–1980 and the same rate was
reported between the years 1988–1992.2,15 The reason
for regional difference in the incident rates is not clear.
Previous authors have suggested regional differences in
carcinogen exposure or diet along with potential
differences in regional awareness of oral lesions that
might represent premalignancy or oral cancer.1 Further
detailed investigation is required in order to confirm
these hypotheses.
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Table 4. Tongue cancer in South Australia,
1977–2001: Age-standardized incidence and
mortality rates of tongue cancer per 100 000
standard world population (95 per cent CI) for the
three periods of 1977–1985, 1986–1993 and
1994–2001
Incidence Mortality
Year Male Female Male Female
1977-1985 0.98 0.46 0.67 0.26
(1.22, 0.74) (0.60, 0.31) (0.86, 0.47) (0.37, 0.15)
1986-1993 1.05 0.49 0.94 0.22
(1.29, 0.81) (0.64, 0.34) (1.17, 0.72) (0.31, 0.13)
1994-2001 1.15 0.45 0.85 0.36
(1.40, 0.90) (0.59, 0.32) (1.06, 0.65) (0.48, 0.24)
Fig 2. Kaplan-Meier survival curves for tongue cancer by periods of
diagnosis: 1977-1985, 1986-1993 and 1994-2001.
Fig 3. Kaplan-Meier survival curves for tongue cancer by sex.
Fig 4. Kaplan-Meier survival curves for tongue cancer by age
groups.
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The results of the present study indicate that there
was no significant difference in male incidence or
mortality in South Australia over the three time
periods. This is consistent with other reports which
indicate the rates of tongue cancer in Australia have
remained stable over the years with the exception of
New South Wales where both incidence and mortality
rates are increasing.2,13,16 Macfarlane et al.16 believe this
pattern is consistent with Australian trends in per
capita decline in consumption of tobacco and alcohol,
and increased consumption of fruit and vegetables,
which is considered to have a protective role against
oral cancer. The incidence and mortality of tongue
cancer in females in South Australia are low and have
remained stable, similar to that reported in other
regions of Australia and United States.2,17 In contrast,
there is an increasing incidence and mortality for
tongue cancer in Europe and the United States,
particularly amongst young adult males and some
female populations.2,17
The five-year survival rate for tongue cancer has not
improved over the 24-year period. This is a common
finding in many reports on oral cancer, despite
significant advances in surgical resection techniques,
reconstruction, radiation therapy and
chemotherapy.16,18 The most important clinical
prognostic predictor for survival is the TNM stage at
the time of diagnosis.4 Cure rates decrease by
approximately 50 per cent when lymph node metastasis
occurs.19 The lack of improvement in survival rates of
tongue cancer indicates that these cancers are not being
diagnosed at an early stage. Delays in diagnosis,
particularly for base of tongue cancers, subsequently
lead to delays in treatment, which in turn allows local
extension of the lesion and an increased risk for
metastatic spread. This ultimately translates to a poorer
outcome for the patient.4,7,20
Of the variables available on the South Australian
Cancer Registry population-based database, univariate
analysis revealed that sex, age and sub-site of tongue
were significant predictors for tongue cancer survival.
The poorer five-year survival for males compared with
females can be explained partly by sub-site distribution.
Male cases had a significantly higher proportion of
lesions involving the base of the tongue (Table 2).
Kantola et al.4 also noted the inter-relationships
between various prognostic factors in tongue cancer
and demonstrated that several demographic factors
significantly related to clinical TNM stage. It was
found that male patients had significantly more neck
lymph node involvement and that older age is
significantly related to carcinoma spread outside the
tongue.6
The fact that older people had significantly poorer
five-year survival from tongue cancer may be due to a
number of factors including delay in diagnosis, poorer
nutritional and immunological status and reduced
ability to withstand aggressive treatment modalities
such as radiotherapy or surgery.21,22 Many studies have
specifically addressed the relationship between age and
prognosis for tongue SCC and offered conflicting
conclusions. Some studies have reported that younger
age was associated with poor prognosis;22,23 others have
found it to be a positive prognostic influence,24,25 or to
have no influence at all.26,27 Some authors have
proposed that the patient population regarded as
‘young’ patients with oral SCC (generally defined as
less than 35 or 40 years of age) may be composed of
several subsets of patients with variable clinical
course.24,28 In this study, there were 50 cases (8.18 per
cent) reported in persons 40 years or younger. Many
studies have addressed the issue of oral SCC in younger
patients. Younger patients consistently make up less
than five per cent of head and neck SCC patients in
reported series.14 The tongue is the most frequently
involved site and the involvement of this site is
increasing in incidence.6,24,29 Knowledge of the aetiology,
clinical behaviour and effective management of oral
SCC in young adults is limited (primarily by the small
sample size) and is sometimes contradictory between
studies. Tobacco and alcohol are not always implicated
in the aetiology of oral SCC of young adults, and the
pathogenic role of other recreational drugs, such as
marijuana, remain unclear.6,30 This suggests that other
external or internal factors play a role in the
development of the disease in young adults. A genetic
basis for oral SCC in young adults has been proposed,31
but any causative role for infective agents such as
Epstein-Barr virus (EBV), human papillomavirus
(HPV), hepatitis C, hepatitis G viruses or human
immunodeficiency virus (HIV) remains to be
established.32,33 More recent studies have suggested that
age alone is not predictive of disease-free survival and
that traditional predictors of survival outcome such as
stage, status of surgical margins, and presence of nodal
metastasis are more important than age.25-28,34
Sub-site distribution of tongue cancer also influences
survival. The more posterior the tumour, the poorer the
survival is likely to be.4,35 In particular, base of tongue
cancer has significantly worse survival than other sub-
sites and is the most significant indicator of poor
survival, even after controlling for age and sex in the
multivariate analysis. This finding is consistent with
Fig 5. Kaplan-Meier survival curves for tongue cancers by sub-sites.
other reports.35,36 Nason et al.35 reported that disease-
specific survival at five years for the tongue base was 26
per cent, compared with 64 per cent for the anterior
tongue. Cancers of the anterior two-thirds of the
tongue tend to be better differentiated and are usually
detected earlier than those of the posterior one-third.37
Base of tongue cancers are typically asymptomatic in
the early stages and are not easily detectable clinically,
as a result, presentation is often late. It has been
reported that 71 per cent of patients with tongue base
tumours had advanced stages of disease at presentation
compared with 32 per cent for the anterior tongue.21 In
addition, there is a high incidence of cervical node
metastases associated with SCC of the base of tongue,
with 60 per cent or more of patients having ipsilateral
nodal disease at the time of initial presentation.3,7 Due
to the relatively rich lymphatic network supplying the
tongue and the tendency of these lymphatic channels to
drain to both sides of the neck, delays in the detection
of inconspicuous tumours will increase the chance for
nodal metastasis and significantly reduce survival
rate.3,4,7
CONCLUSION
This study analysed the epidemiology of tongue
cancer in South Australia between the years
1977–2001. The finding that the incidence and survival
of tongue cancer has not improved reflects a need for
increasing patient and general public awareness of this
disease and its risk factors. Regular professional oral
cancer examination needs to be emphasized. Clinicians
should be aware of the potential for tongue cancer to
occur in younger patients who may not have obvious
risk factors, such as tobacco and alcohol use. The most
important message is that early detection and diagnosis
of tongue cancers will greatly improve not only the
survival rates of tongue cancer but also patients’ quality
of life as a consequence of less radical and therefore
debilitating treatment.
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